279 related articles for article (PubMed ID: 10523065)
1. Where are we going with SSRIs?
Isaac M
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S101-6. PubMed ID: 10523065
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
3. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Zohar J; Westenberg HG
Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
[TBL] [Abstract][Full Text] [Related]
4. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
Gorman JM; Kent JM
J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
Berk M
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
8. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
Bourin M
Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
Bailly D
Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
[TBL] [Abstract][Full Text] [Related]
10. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of selective serotonin reuptake inhibitor (SSRI) in the treatment of depression].
Semba J
Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):79-84. PubMed ID: 10976459
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
Figgitt DP; McClellan KJ
Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
[TBL] [Abstract][Full Text] [Related]
14. Are SSRIs really more effective for anxious depression?
Panzer MJ
Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
[TBL] [Abstract][Full Text] [Related]
15. [Biological basis of anxiety disorders and serotonergic anxiolytics].
Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
[TBL] [Abstract][Full Text] [Related]
16. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
Vaswani M; Linda FK; Ramesh S
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
[TBL] [Abstract][Full Text] [Related]
17. Overview of antidepressants currently used to treat anxiety disorders.
Feighner JP
J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
Seidel L; Walkup JT
J Child Adolesc Psychopharmacol; 2006; 16(1-2):171-9. PubMed ID: 16553537
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin-reuptake inhibitors: an update.
Masand PS; Gupta S
Harv Rev Psychiatry; 1999; 7(2):69-84. PubMed ID: 10471245
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine: current status in psychiatry.
Pae CU; Patkar AA
Expert Rev Neurother; 2007 Feb; 7(2):107-20. PubMed ID: 17286545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
